It is very important to remark that Palbociclib mechanism of action directly targets the transcriptional activity of p53 after exposure to radiation and therefore, its efficacy might be limited to p53-expressing CRC tumors (Fernandez-Aroca et al., 2019). The gene discussed is TP53; the disease is colorectal carcinoma.